Abstract
The ongoing global COVID-19 pandemic calls for unprecedented efforts from the biosciences. In return it offers the opportunity to study an emerging pathogen and follow its spread and adaptation to the human host in real time. So far, the virus SARS-CoV-2 has only changed very subtly, which is good news for vaccination hopes. Michael Gross reports.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have